Navigation Links
MedCath Corporation Announces Decision to Consider Strategic Options
Date:3/1/2010

CHARLOTTE, N.C., March 1 /PRNewswire-FirstCall/ -- MedCath Corporation (Nasdaq: MDTH) announced today that its Board of Directors (the "Board") has formed a Strategic Options Committee (the "Committee") composed solely of independent directors to consider the sale either of MedCath or the sale of its individual hospitals and other assets. Navigant Capital Advisors ("Navigant") has been retained as its financial advisor to assist the Committee in this process.  Due to this engagement, Dr. Edward R. Casas, a senior managing director of Navigant Capital Advisors, resigned voluntarily from MedCath's Board and will not stand for reelection to MedCath's Board at its upcoming annual stockholders' meeting on March 3, 2010.

There can be no assurance that this process will result in any specific transaction.  This announcement contains forward-looking statements, including statements relating to a possible sale of MedCath or its assets.  There are many factors that would affect MedCath's, the Board's or the Committee's views and decisions regarding these events and material facts and circumstances may change. The Company does not undertake, and specifically disclaims any obligation to update the statements in this release or provide ongoing disclosure regarding the Committee's process.

MedCath, headquartered in Charlotte, N.C., is a health care provider focused on high acuity services with the diagnosis and treatment of cardiovascular disease being a primary service offering.  MedCath owns an interest in and operates ten hospitals with a total of 825 licensed beds, located in Arizona, Arkansas, California, Louisiana, New Mexico, South Dakota and Texas.  In addition, MedCath and its subsidiary MedCath Partners provide services in diagnostic and therapeutic facilities in various states.

SOURCE MedCath Corporation

Back to top

RELATED LINKS
http://www.medcath.com

'/>"/>

SOURCE MedCath Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. MedCath Enters Definitive Agreement To Sell Heart Hospital of Austin
2. MedCath Corporation Reports First Quarter Earnings
3. MedCath Receives Licensure and Accreditation for New Hualapai Mountain Medical Center
4. MedCath Names Art Parker Executive Vice President and Chief Financial Officer
5. Jim Deal Appointed to MedCaths Board of Directors
6. MedCath Corporation Reports Third Quarter Earnings
7. MedCath Corporation to Hold Conference Call on Third Quarter Results
8. Jeff Hinton to Leave MedCath
9. MedCath Corporation Reports Second Quarter Earnings and Provides Update to Internal Assessment
10. MedCath Corporation to Hold Conference Call on Second Quarter Results
11. David Covert to Join MedCath as Senior Vice President, Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief ... a minimum wage raise to $12 an hour by 2020 and then adjusting it yearly ... lost value of the minimum wage, assure the wage floor does not erode again, and ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Grove Investment Group (TGIG), has initiated cultivation and processing operations at its production ... and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
Breaking Medicine Technology: